12th International Clinical Cancer Genomics Conference: Accelerating Progress in Precision Medicine for Cancer: The Time is Now

Event

12th International Clinical Cancer Genomics Conference: Accelerating Progress in Precision Medicine for Cancer: The Time is Now

presented by UChicago Medicine

1 other would like to attend.

Register Now

Thursday, April 18, 2024 1 PM - Sunday, April 21, 2024 11:45 AM America/Chicago

200 N Columbus Dr Chicago, IL 60601 United States

Event info

OVERVIEW

Rapid advances in genomic technologies have revolutionized our approach to risk-adapted cancer treatments and screening for early detection or prevention of cancer, heralding the era of precision health care across the continuum of cancer care. Knowledge of the genomic landscape and immune microenvironment of common cancers has fueled the need to identify cancer patients and healthy individuals at risk of the most lethal but treatable types of cancers where more intensive surveillance and personalized management plan can be implemented to improve overall survival. A classic example is identifying BRCA1 gene mutation carriers to preempt or prevent the development of lethal basal-like breast cancers and treating BRCA-Associated cancer with Parp Inhibitors. Identifying Lynch Syndrome patients led to the development of curative neoadjuvant immunotherapy approaches for Rectal Cancer.

Accelerating Progress in Precision Medicine for Cancer: The Time is Now will provide an interdisciplinary educational forum in which to update state-of-the-art science in cancer genomics, including Artificial Intelligence, discuss real-world cases, curate interesting pedigrees, and prepare case summaries to disseminate new knowledge and evidence-based management of high-risk patients and their at-risk family members. The goal of this educational activity is to equip healthcare providers with practical tools and knowledge to accelerate progress in precision medicine for cancer.

OPTIONAL PRE-CONFERENCE WORKSHOP AVAILABLE!
Precision Medicine in Practice Primer and Cased-Based Workshop

April 18, 2024 | 1:00 pm-5:00 pm CT
Registration for the optional Pre-conference Workshop is an additional $200. You must be registered to attend the full course to be eligible for the pre-conference workshop.

TARGET AUDIENCE

This activity has been designed for physicians, physician assistants, advanced nurse practitioners, genetic counselors, oncology nurses, and other healthcare professionals currently involved in providing cancer genetics risk assessment services or initiating such services in their health care system. Special efforts will be made to meet the needs of clinicians practicing in non-academic centers and geographically and/or socioeconomically underserved communities.

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

Review advances in genetics, genomics, and next-generation Omics technologies transforming precision medicine for cancer;
Cite controversies in cancer risk assessment and genomic testing for risk-adapted management, including integration of polygenic risk score into preventive care;
Discuss emerging concepts in Artificial Intelligence and Deep Learning to advance population health management;
Describe social stigma and barriers faced by vulnerable populations in adopting genomically informed care;
Identify gene-environment interactions that influence response to therapy in hematologic malignancies and solid tumors, including Breast, Ovarian, Colon, Lung and Kidney cancers
Recognize advances in BRCA1 and BRCA2 research with special emphasis on new models of patient-centric clinical trials and remote monitoring for BRCA-associated cancers;
Integrate genomically-informed cancer risk management, prevention, and targeted therapeutics recommendations into clinical cases.

ACCREDITATION

Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 22.25 PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Login

Login

Join VuMedi